CA2640614A1 - Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential - Google Patents

Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential Download PDF

Info

Publication number
CA2640614A1
CA2640614A1 CA002640614A CA2640614A CA2640614A1 CA 2640614 A1 CA2640614 A1 CA 2640614A1 CA 002640614 A CA002640614 A CA 002640614A CA 2640614 A CA2640614 A CA 2640614A CA 2640614 A1 CA2640614 A1 CA 2640614A1
Authority
CA
Canada
Prior art keywords
biomarker
biomarkers
adsorbent
embryo
developmental potential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002640614A
Other languages
English (en)
French (fr)
Inventor
Sergio C. Oehninger
O. John Semmes
Lisa H. Cazares
Silvina Bocca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2640614A1 publication Critical patent/CA2640614A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002640614A 2006-01-27 2007-01-29 Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential Abandoned CA2640614A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76249206P 2006-01-27 2006-01-27
US60/762,492 2006-01-27
PCT/US2007/002456 WO2007089734A2 (en) 2006-01-27 2007-01-29 Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential

Publications (1)

Publication Number Publication Date
CA2640614A1 true CA2640614A1 (en) 2007-08-09

Family

ID=38327982

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002640614A Abandoned CA2640614A1 (en) 2006-01-27 2007-01-29 Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential

Country Status (6)

Country Link
US (1) US20090215085A1 (enExample)
EP (1) EP1994408A4 (enExample)
JP (1) JP2009524829A (enExample)
AU (1) AU2007209980A1 (enExample)
CA (1) CA2640614A1 (enExample)
WO (1) WO2007089734A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006007560A2 (en) 2004-07-01 2006-01-19 University Of Pennsylvania Targeted protein replacement for the treatment of lysosomal storage disorders
US20090075293A1 (en) * 2007-09-07 2009-03-19 Pevsner Paul H Methods for predicting embryo viability
WO2009075862A1 (en) * 2007-12-11 2009-06-18 New York University School Of Medicine Method of assessing viability of embryos in vitro
US10350277B2 (en) 2011-09-07 2019-07-16 Icahn School Of Medicine At Mount Sinai Ceramidase and cell differentiation
RU2474823C1 (ru) * 2011-09-26 2013-02-10 Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования качества эмбрионов в программе экстракорпорального оплодотворения
ES2786128T3 (es) 2012-06-01 2020-10-08 Icahn School Med Mount Sinai Niveles de ceramida en el tratamiento y prevención de infecciones
JP6832158B2 (ja) 2013-03-14 2021-02-24 アイカーン スクール オブ メディシン アット マウント サイナイ 治療用酸性セラミダーゼ組成物ならびにそれを作製および使用する方法
CN107003319B (zh) * 2014-09-24 2019-12-31 曼普知识产权控股有限公司 提供妊娠预测的方法
CN111279421B (zh) * 2017-09-29 2024-04-09 布里格姆妇女医院 人类胚胎的自动评价
JP7134462B2 (ja) * 2018-03-28 2022-09-12 国立大学法人 大分大学 胚の評価方法
RU2706683C1 (ru) * 2019-06-05 2019-11-20 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ прогнозирования готовности эндометрия к успешной имплантации эмбриона у женщин с маточной формой бесплодия с использованием компьютерной морфометрии
CA3144694A1 (en) * 2019-07-25 2021-01-28 Jose A. Horcajadas Identification of viable human embryos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462454B (sv) * 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
US6283761B1 (en) * 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
PT700521E (pt) * 1993-05-28 2003-10-31 Baylor College Medicine Metodo e espectrometro de massa para dessorcao e ionizacao de analitos
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5994148A (en) * 1997-06-23 1999-11-30 The Regents Of University Of California Method of predicting and enhancing success of IVF/ET pregnancy
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
CN1169188C (zh) * 1999-04-29 2004-09-29 赛弗根生物系统股份有限公司 具有憎水覆层的气相质谱仪样品支架
ATE313799T1 (de) * 1999-09-27 2006-01-15 Clifford L Librach Nachweis von hla-g
WO2002006829A2 (en) * 2000-07-18 2002-01-24 Correlogic Systems, Inc. A process for discriminating between biological states based on hidden patterns from biological data
US7113896B2 (en) * 2001-05-11 2006-09-26 Zhen Zhang System and methods for processing biological expression data
US7541003B2 (en) * 2001-07-17 2009-06-02 Bio-Rad Laboratories, Inc. Latex based adsorbent chip
US20020193950A1 (en) * 2002-02-25 2002-12-19 Gavin Edward J. Method for analyzing mass spectra
JP2005526972A (ja) * 2002-05-02 2005-09-08 シファーゲン バイオシステムズ， インコーポレイテッド 多糖系ヒドロゲルをコーティングした表面を有するバイオチップ
EP1552302B1 (en) * 2002-07-24 2009-03-25 Bio-Rad Laboratories, Inc. Protein interaction difference mapping
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US7572601B2 (en) * 2004-10-15 2009-08-11 Northwestern University Compositions and methods for determining oocyte development potential

Also Published As

Publication number Publication date
US20090215085A1 (en) 2009-08-27
EP1994408A2 (en) 2008-11-26
AU2007209980A1 (en) 2007-08-09
WO2007089734A3 (en) 2008-07-24
WO2007089734A2 (en) 2007-08-09
EP1994408A4 (en) 2009-05-06
JP2009524829A (ja) 2009-07-02

Similar Documents

Publication Publication Date Title
US20090215085A1 (en) Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential
US8173433B2 (en) Platelet biomarkers for cancer
JP5011410B2 (ja) 生体液のプロテオーム分析
US20230086542A1 (en) Compositions for endometriosis assessment having improved specificity
Nyalwidhe et al. The search for biomarkers of human embryo developmental potential in IVF: a comprehensive proteomic approach
US8440409B2 (en) Protein C inhibitor as a biomarker for prostate cancer
AU2012217717B2 (en) Compositions and methods for diagnosing ovarian cancer
EP3182126A2 (en) Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome
CA2914918C (en) Compositions and methods for ovarian cancer assessment having improved specificity
US20080026410A1 (en) Biomarkers for Bladder Cancer
US20230127069A1 (en) Compositions for ovarian cancer assessment having improved specificity and sensitivity
US8221984B2 (en) Biomarkers for ovarian cancer
AU2011316844A1 (en) Prognostic biomarkers in patients with ovarian cancer
US10859567B2 (en) Viability assessment of in vitro cultured human embryos from the culture medium
CA2574831A1 (en) Biomarkers for bladder cancer
HK40102817A (en) Compositions for ovarian cancer assessment having improved specificity
WO2024119119A1 (en) Compositions for endometriosis assessment having improved specificity
KATZ-JAFFE Evaluation of embryo quality 19

Legal Events

Date Code Title Description
FZDE Dead